Abstract
Recent advances in obesity management reflect the integration of pharmacological, surgical, and behavioral interventions, yet sustainable long-term outcomes remain elusive due to high attrition rates, the complexity of protocol compliance – and for some, costs, risks, and serious side effects. This research combined a patented nutraceutical designed to naturally stimulate serotonin, a biologic hunger agonist, to thereby aid in appetite control and facilitate weight loss through ‘Targeted Eating,’ a single, unrestricted daily meal protocol. Initial results from this ‘real world’ user study indicate promising weight management outcomes and compliance with this eating strategy. By exploring the evolutionary biology of perceived hunger and the anatomy associated with episodic versus circadian consumption, the study thus proposes a paradigm shift in obesity treatment and suggests further approaches to provide innovative solutions to the global obesity crisis.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call